Endometrial Biopsy Clinical Trial
Official title:
A Muticenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of a Single-Dose of COL-1077 in Women Undergoing Transvaginal Pipelle-Directed Endometrial Biopsy
The purpose of this study is to determine if COL-1077 (10% lidocaine vaginal bioadhesive gel) will be effective as an acute-use anesthetic and can decrease the pain intensity associated with gynecologic procedures using endometrial biopsy as a representative procedure.
COL-1077 is to be self-administered by patients prior to an outpatient transvaginal pipelle-directed endometrial biopsy with tenaculum placement in otherwise healthy women requiring biopsy. ;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01908738 -
Effectiveness of Paracervical Block Versus Lidocaine Spray During Endometrial Biopsy
|
N/A | |
Withdrawn |
NCT00953641 -
Vaginal Misoprostol for Cervical Ripening Prior to Endometrial Biopsy
|
Phase 3 | |
Recruiting |
NCT06180317 -
The Effect of Virtual Reality on Anxiety and Pain During Endometrial Biopsy
|
N/A | |
Recruiting |
NCT01963819 -
Therapeutic Endometrial Biopsy
|
N/A | |
Completed |
NCT00200226 -
Oral Misoprostol Before Endometrial Biopsy
|
Phase 3 |